Trexquant Investment’s Lipocine LPCN Stock Holding History

Trexquant Investment’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,194	Closed	-$240K	–	1167
2015 Q3	$240K	Buy	+1,194	New	+$276K	0.02%	931

Other funds holding LPCN

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Trexquant Investment's LPCN Position: Q4 2015 in Review

Trexquant Investment sold out of Lipocine (LPCN) in Q4 2015, closing a stake of 1,194 shares — an estimated $240K sold.

Trexquant Investment first reported a position in LPCN in Q3 2015 and held it in 1 quarter. The position peaked at $240K in Q3 2015. 47 funds tracked by Wall St. Rank hold LPCN as of Q4 2015.

Trexquant Investment reported no remaining Lipocine position as of Q4 2015 after selling out during the quarter.
Trexquant Investment sold 1,194 Lipocine shares in Q4 2015, an estimated $240K.
Trexquant Investment first reported a position in Lipocine in Q3 2015 and held it in 1 quarter.
Trexquant Investment's Lipocine position peaked at $240K in Q3 2015.
47 funds tracked by Wall St. Rank held Lipocine as of Q4 2015.

Based on Trexquant Investment's 13F filing for Q4 2015, filed 10 Feb 2016.